ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD multiplex analysis system for routine and focused multiplex analysis of DNA, RNA or protein biomarkers. The company was founded in 1994 and is based in Guildford, the United Kingdom.

Diagnostik und Forschung

Ms. Anne-Sophie  Pailhes-Jimenez

Head of R&D - ANGLE Europe Ltd.

Mr. Paul  Smith

Chief Commercial Officer

Mr. Michael  O'Brien

Bus. Devel. Director

Dr. Madeline  Repollet

Head of Clinical Laboratories

Mr. Andrew David William Newland

Founder, Chief Executive Officer & Executive Director

Mr. Ian Francis Griffiths

Chief Financial Officer, Fin. Director, Company Sec. & Executive Director

Mr. Martin  Cooke

Director of Operations & Regulatory Affairs

Dr. Karen  Miller Ph.D.

Chief Scientific Officer

Mr. Andrew John Holder

Head of Investor Relations

Mr. Brett  Swansiger

Mr. Nick  Claxton

Senior Vice President of Commercial Operations

Name	Marktkapitalisierung
Thyrocare Technologies Limited	0M
HTG Molecular Diagnostics, Inc.	0M
Global Cord Blood Corporation	0M
Diaceutics PLC	0M
Myriad Genetics, Inc.	0M
Centogene N.V.	0M
DermTech, Inc.	0M
HTG Molecular Diagnostics, Inc.	0M
SQI Diagnostics Inc.	0M

ANGLE plc

ANGLE plc Liste der Konkurrenten

Wichtigste Wettbewerber